에 대한 최신 뉴스 Albemarle (NYSE:ALB) 주식

Albemarle

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.

Equities

Large Cap

Macro Economic Events

Mid Cap

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

DXCM

ILMN

MRNA

NVDA

S&amp;P 500과 나스닥 100이 월요일 상승세를 이어갔다. 이로써 두 지수는 모두 8일 연속으로 상승을 기록하며 연방준비제도(연준)의 금리 인하를 앞두고 미국 경제 전망과 금융 상황이 개선됨에 따라 트레이더들이 낙관론을 유지하고 있는 것을 보여준다.

S&amp;P 500과 나스닥 100은 월가의 불안감이 사라져 8일 연속 상승: 월요일의 상승 주식

News

Movers

ALGN

BALL

BNTX

ENPH

FSLR

MBLY

RIVN

FLSR

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 게임스탑(NYSE:GME)의 주가는 연간 주주총회 이후 지난주에 18.61% 하락했으며, CEO 라이언 코헨은 비용 절감을 통해 수익성을 향한 전략적 전환을 강조했다.

게임스탑과 자빌은 지난주 최악의 성과를 보인 10개의 대형주 중 일부 (6월 16일-6월 22일)

Government

Macro Notification

Small Cap

Markets

Tech

ANET

AVGO

ETSY

GNRC

INCY

PARA

QRVO

SIRI

SMCI

TEAM

TSLA

XLRE

Select Sector SPDR-Consumer Discretionary

기술주가 시장 상승세를 주도함에 따라 나스닥 100 지수는 목요일에 4일 연속 올랐다. 이 지수는 0.6% 오른 19,576포인트로 마감하며 사상 최고치를 경신했다.S&amp;P 500 지수도 4일 연속 올랐다. 목요일 이 지수는 0.2% 상승해 사상 최고치인 5,433포인트를 기록했다. 실망스러운 실업 수당 청구 데이터로 인한 오전 하락세에서 반등했다.

나스닥 100, S&amp;P 500은 기술주가 우위를 되찾으며 사상 최고치로 마감: 상승주와 하락주

Albemarle Corp

ALBA MINERALS RESOCES PLC by Alba Minerals Resources PLC.

Alba Mineral Resources PLC

ALIBABA HEALTH UNSP/ADR by Alibaba Health Information Technology Ltd

Alibaba Health Information Technology Ltd

Albemarle Corp PRF PERPETUAL USD 1000 - Ser A 1/20th Pref St

ALIBABA HEALTH INFO TECH by Alibaba Health Information Technology Ltd

ALPHA SVCS & HLDGS S A by Alpha Services and Holdings SA

Alpha Services and Holdings SA

ALPHA SVCS & HLDGS S/ADR by Alpha Services and Holdings SA

ALBERT LABS INTL CORP by ALBERT LABS INTL CORP.

Albert Labs International Corp

Avalon Globocare Corp

AllianceBlock - United States Dollar

COMMUTY CAP BNCSHS INC by Community Capital Bancshares, Inc.

Community Capital Bancshares Inc

Albemarle Corporation Depositary Shares each representing a 1/20th of 7.25% Series A Mandatory Convertible Preferred Stock

WIIM

ASPI

BSLK

CRKN

CRML

CTVA

FEAM

MATV

MEOH

NITO

SCCO

TROX

Shares of companies in the broader materials sector are trading lower amid overall market uncertainty after President Trump confirmed March 4 tariffs.

<p>Piper Sandler  analyst Charles Neivert   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Underweight and lowers the price target from $90 to $85.</p>


Price Target

Analyst Ratings

Piper Sandler Maintains Underweight on Albemarle, Lowers Price Target to $85

<p>Morgan Stanley  analyst Vincent Andrews   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Underweight and lowers the price target from $73 to $68.</p>


Morgan Stanley Maintains Underweight on Albemarle, Lowers Price Target to $68

<p>Scotiabank  analyst Ben Isaacson   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Sector Perform and lowers the price target from $85 to $75.</p>


Scotiabank Maintains Sector Perform on Albemarle, Lowers Price Target to $75

<p>Keybanc  analyst Aleksey Yefremov   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Overweight and lowers the price target from $127 to $122.</p>


Keybanc Maintains Overweight on Albemarle, Lowers Price Target to $122

<p>Truist Securities  analyst Peter Osterland   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Hold and lowers the price target from $96 to $85.</p>


Truist Securities Maintains Hold on Albemarle, Lowers Price Target to $85

<p>Throughout the last three months, 4 analysts have evaluated Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $97.5, with a high estimate of $105.00 and a low estimate of $86.00. This upward trend is evident, with the current average reflecting a 1.56% increase from the previous average price target of $96.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739473220_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Albemarle by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$86.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Hold</td>
<td>$96.00</td>
<td>-</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$103.00</td>
<td>$79.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Albemarle. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Albemarle compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Albemarle's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Albemarle's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALB/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Albemarle analyst ratings.</strong></a></p>
<h2>Get to Know Albemarle Better</h2>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<h3>Albemarle: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> Albemarle's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately <strong>-41.37%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Albemarle's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-81.99%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-13.07%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Albemarle's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-6.2%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Albemarle's debt-to-equity ratio is below the industry average at <strong>0.45</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing Albemarle: Insights From 4 Financial Analysts

<p>UBS  analyst Joshua Spector   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Neutral and lowers the price target from $99 to $86.</p>


UBS Maintains Neutral on Albemarle, Lowers Price Target to $86

<ul>
<li>Further reducing expected full-year 2025 capital expenditures by $100 million; now targeting capital expenditures in the range of $700 and $800 million, or down more than 50% year-over-year.</li>
</ul>


Guidance

Albemarle Introduces New Full-year 2025 Outlook: Line Of Sight To Breakeven Free Cash Flow In 2025

<p>Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.70) by 55.71 percent. This is a 158.92 percent decrease over earnings of $1.85 per share from the same period last year.  The company reported quarterly sales of $1.23 billion which missed the analyst consensus estimate of $1.34 billion by 7.82 percent.  This is a 47.75 percent decrease over sales of $2.36 billion the same period last year.</p>


Earnings

Earnings Misses

Albemarle Q4 2024 Adj EPS $(1.09) Misses $(0.70) Estimate, Sales $1.23B Miss $1.34B Estimate

ACRE

AEIS

AEMD

ALCO

ALKS

AMWL

ASND

ASPN

ATRC

AVXL

AYTU

BIIB

BROS

BXMT

CAMT

CGNX

CHEF

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

<p>The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Albemarle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>)</strong></h3>
<ul>
<li>On Jan. 28, Truist Securities analyst Peter Osterland initiated coverage on Albemarle with a Hold rating and announced a price target of $96. The company' stock fell around 18% over the past month and has a <a href="https://www.benzinga.com/quote/ALB">52-week low of $71.97</a>.</li>
<li><strong>RSI Value:</strong> 25.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>ALB Price Action:</strong> Shares of Albemarle fell 2.9% to close at $75.14 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1">ALB news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="807" height="782" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040024/image-2-23.png" alt="" class="wp-image-776084" style="width:504px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040024/image-2-23.png 807w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040024/image-2-23-300x291.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040024/image-2-23-768x744.png 768w" sizes="(max-width: 807px) 100vw, 807px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Purecycle Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>On Feb. 5, PureCycle announced a $33 million financing transaction. PureCycle CEO Dustin Olson said, &#8220;We&#8217;re excited to bring on a new partner like Pleiad Investment Advisors. We are making material progress with trials and are continuing to pursue commercial success in fiber and other applications.&#8221; The company's stock fell around 12% over the past month and <a href="https://www.benzinga.com/quote/PCT">has a 52-week low</a> of $4.26.</li>
<li><strong>RSI Value:</strong> 28.5</li>
<li><strong>PCT Price Action:</strong> Shares of Purecycle Technologies fell 2.1% to close at $8.48 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1">PCT stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040133/image-87.png" alt="" class="wp-image-776085" style="width:539px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040133/image-87.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040133/image-87-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040133/image-87-768x707.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Northern Technologies International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTIC#NASDAQ">NTIC</a>)</strong></h3>
<ul>
<li>Northern Technologies International is expected to release its fiscal 2025 first-quarter financial results on Thursday, Jan. 9, before the opening bell. The company's stock fell around 16% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/NTIC"> low of $11.15</a>.</li>
<li><strong>RSI Value:</strong> 27.6</li>
<li><strong>NTIC Price Action:</strong> Shares of Northern Technologies International fell 1% to close at $11.16 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1">NTIC shares</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021125&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040227/image-88.png" alt="" class="wp-image-776087" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040227/image-88.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040227/image-88-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/11040227/image-88-768x724.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></strong></li>
</ul>


Long Ideas

Pre-Market Outlook

Trading Ideas

NTIC

Top 3 Materials Stocks Which Could Rescue Your Portfolio This Quarter

<p>Deep-pocketed investors have adopted a bullish approach towards Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ALB usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 16 extraordinary options activities for Albemarle. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 56% leaning bullish and 37% bearish. Among these notable options, 8 are puts, totaling $1,173,743, and 8 are calls, amounting to $378,083.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $110.0 for Albemarle, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Albemarle's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Albemarle's whale trades within a strike price range from $60.0 to $110.0 in the last 30 days. </p>
<h3>Albemarle 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739213125_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$0.54</td>
<td>$0.38</td>
<td>$0.41</td>
<td>$60.00</td>
<td>$410.0K</td>
<td>6</td>
<td>10.0K</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.55</td>
<td>$1.44</td>
<td>$1.55</td>
<td>$70.00</td>
<td>$310.0K</td>
<td>721</td>
<td>2.0K</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.1</td>
<td>$4.0</td>
<td>$3.9</td>
<td>$76.00</td>
<td>$195.0K</td>
<td>0</td>
<td>500</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$110.00</td>
<td>$75.6K</td>
<td>357</td>
<td>210</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$8.7</td>
<td>$8.65</td>
<td>$8.7</td>
<td>$75.00</td>
<td>$74.8K</td>
<td>1.0K</td>
<td>116</td>
</tr>
</tbody>
</table>
</p>
<h3>About Albemarle</h3>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<p>In light of the recent options history for Albemarle, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Albemarle Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 1,551,608, the ALB's price is down by -1.54%, now at $76.17. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 2 days.</li>
</ul>
<h3>What Analysts Are Saying About Albemarle</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $96.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Truist Securities downgraded its rating to Hold, setting a price target of $96. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Albemarle with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Looking At Albemarle's Recent Unusual Options Activity

<p>Deep-pocketed investors have adopted a bullish approach towards Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ALB usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Albemarle. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 72% leaning bullish and 9% bearish. Among these notable options, 9 are puts, totaling $749,825, and 2 are calls, amounting to $64,650.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $150.0 for Albemarle, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Albemarle's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Albemarle's significant trades, within a strike price range of $60.0 to $150.0, over the past month.</p>
<h3>Albemarle 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738944981_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$16.5</td>
<td>$13.75</td>
<td>$13.95</td>
<td>$70.00</td>
<td>$418.5K</td>
<td>330</td>
<td align="right">302</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$72.5</td>
<td>$72.1</td>
<td>$72.5</td>
<td>$150.00</td>
<td>$72.5K</td>
<td>175</td>
<td align="right">10</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$10.0</td>
<td>$8.35</td>
<td>$9.18</td>
<td>$88.00</td>
<td>$52.3K</td>
<td>7</td>
<td align="right">57</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.6</td>
<td>$5.1</td>
<td>$5.1</td>
<td>$80.00</td>
<td>$50.6K</td>
<td>10.8K</td>
<td align="right">15</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$19.35</td>
<td>$18.95</td>
<td>$19.35</td>
<td>$65.00</td>
<td>$34.8K</td>
<td>220</td>
<td align="right">3</td>
</tr>
</tbody>
</table>
</p>
<h3>About Albemarle</h3>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<h3>Albemarle's Current Market Status</h3>
<ul>
<li>With a volume of 823,273, the price of ALB is down 0.0% at $79.0. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 5 days.</li>
</ul>
<h3>Expert Opinions on Albemarle</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $96.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Truist Securities downgraded its action to Hold with a price target of $96. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Albemarle options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Behind the Scenes of Albemarle's Latest Options Trends

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Truist Securities analyst Peter Osterland initiated coverage on <strong>Albemarle Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Hold rating and announced a price target of $96. Albemarle shares closed at $88.78 on Monday. <a href="https://www.benzinga.com/quote/ALB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Juan Sanabria initiated coverage on <strong>Tanger Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKT#NYSE">SKT</a>) with a Market Perform rating and announced a price target of $36. Tanger shares closed at $32.68 on Monday. <a href="https://www.benzinga.com/quote/SKT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Peter Osterland initiated coverage on <strong>Westlake Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Buy rating and announced a price target of $168. Westlake shares closed at $117.57 on Monday. <a href="https://www.benzinga.com/quote/WLK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Mark Lear initiated coverage on <strong>Expand Energy Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Neutral rating and announced a price target of $96. Expand Energy shares closed at $101.42 on Monday. <a href="https://www.benzinga.com/quote/EXE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Gavin Clark-Gartner initiated coverage on <strong>Mind Medicine (MindMed) Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) with an Outperform rating and announced a price target of $23. Mind Medicine shares closed at $6.90 on Monday. <a href="https://www.benzinga.com/quote/MNMD/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<p>Considering buying WLK stock? Here&#8217;s what analysts think: </p>
<p><figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="608" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-1024x608.png" alt="" class="wp-image-753404" style="width:484px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28071609/image-220.png 1107w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43230206/jim-cramer-is-worried-about-this-consumer-cyclical-stock-7-yield-something-may-be-wrong-here">Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? &#8216;Something May Be Wrong Here&#8217;</a></strong></li>
</ul>


Initiation

MNMD

This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

<p>In the last three months, 6 analysts have published ratings on Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Albemarle and provided 12-month price targets. The average target is $122.33, accompanied by a high estimate of $170.00 and a low estimate of $96.00. Marking an increase of 1.94%, the current average surpasses the previous average price target of $120.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738065646_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Albemarle. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Hold</td>
<td>$96.00</td>
<td>-</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$105.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$103.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$133.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$127.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Colin Rusch</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$171.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Albemarle. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Albemarle compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Albemarle's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Albemarle's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ALB/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Albemarle analyst ratings.</strong></a></p>
<h2>Delving into Albemarle's Background</h2>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<h3>Albemarle's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Albemarle's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately <strong>-41.37%</strong> in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> Albemarle's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-81.99%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Albemarle's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-13.07%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Albemarle's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-6.2%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Albemarle's debt-to-equity ratio is below the industry average. With a ratio of <b>0.45</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying Albemarle: Insights From 6 Analyst Reviews

<p>Truist Securities  analyst Peter Osterland   initiates coverage on Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Hold rating and announces Price Target of $96.</p>


Truist Securities Initiates Coverage On Albemarle with Hold Rating, Announces Price Target of $96

<p>Mizuho  analyst John Roberts   maintains Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) with a Neutral and lowers the price target from $110 to $105.</p>


Mizuho Maintains Neutral on Albemarle, Lowers Price Target to $105

<p><strong>Albemarle's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) short percent of float has risen 3.81% since its last report. The company recently reported that it has <strong>13.19 million shares sold short</strong>, which is 12.81% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 7.19 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Albemarle Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736182816_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Albemarle has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Albemarle's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Albemarle's peer group average for short interest as a percentage of float is 3.04%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Peering Into Albemarle's Recent Short Interest

<p>Financial giants have made a conspicuous bearish move on Albemarle. Our analysis of options history for Albemarle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) revealed 13 unusual trades.</p>
<p>Delving into the details, we found 30% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $329,766, and 5 were calls, valued at $267,310.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $120.0 for Albemarle over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Albemarle's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Albemarle's whale activity within a strike price range from $80.0 to $120.0 in the last 30 days. </p>
<h3>Albemarle Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1735848031_0_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$95.00</td>
<td>$123.6K</td>
<td>683</td>
<td align="right">7</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$18.2</td>
<td>$18.0</td>
<td>$18.08</td>
<td>$100.00</td>
<td>$68.6K</td>
<td>2.1K</td>
<td align="right">98</td>
</tr>
<tr>
<td>ALB</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$28.25</td>
<td>$26.95</td>
<td>$28.2</td>
<td>$80.00</td>
<td>$47.9K</td>
<td>119</td>
<td align="right">17</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.7</td>
<td>$13.6</td>
<td>$13.6</td>
<td>$90.00</td>
<td>$47.6K</td>
<td>1.1K</td>
<td align="right">35</td>
</tr>
<tr>
<td>ALB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$18.15</td>
<td>$18.0</td>
<td>$18.07</td>
<td>$100.00</td>
<td>$43.4K</td>
<td>2.1K</td>
<td align="right">108</td>
</tr>
</tbody>
</table>
</p>
<h3>About Albemarle</h3>
<p>Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.</p>
<p>In light of the recent options history for Albemarle, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Albemarle's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,048,808, the price of ALB is up by 1.27%, reaching $87.17.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 41 days from now.</li>
</ul>
<h3>What The Experts Say On Albemarle</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $103.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Neutral rating on Albemarle with a target price of $103. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Albemarle, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Spotlight on Albemarle: Analyzing the Surge in Options Activity

Dividends

Commodities

Press Releases

Albemarle Announces Quarterly Common Stock Dividend

Albemarle Reports Third Quarter 2024 Results

Opinion

Global Antimony Shortage Is a Ticking Time Bomb for the U.S. Military

Albemarle Corporation to Participate in Virtual Fireside Chat at the Deutsche Bank 9th Annual Lithium & Battery Supply Chain Conference

Albemarle Corporation to Release Fourth-Quarter 2024 Earnings Results on Wednesday, February 12, 2025

Grid Battery Metals Update - Fall 2024 Drilling Results on Its Clayton Valley Lithium Project

Albemarle Reports Fourth Quarter and Full Year 2024 Results

Albemarle Corporation to Participate in February 2025 Investor Conferences

China Leverages Rare Metals Monopoly Amid Tech Trade Tensions

Comments

Albemarle

뉴스

에 대한 최신 뉴스 Albemarle (NYSE:ALB) 주식

월요일, 8월 19, 2024

일요일, 6월 23, 2024

목요일, 6월 13, 2024

월요일, 4월 22, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌